US Patent Issued to Belhaven BioPharma on April 21 for "Compositions, devices, and methods for intranasal delivery of dry powder epinephrine" (North Carolina, Wisconsin Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,517, issued on April 21, was assigned to Belhaven BioPharma Inc. (Raleigh, N.C.).

"Compositions, devices, and methods for intranasal delivery of dry powder epinephrine" was invented by Scott Lyman (Raleigh, N.C.) and Brian Taubenheim (Elkhart Lake, Wis.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Intranasal dry powder epinephrine compositions are described herein. The compositions include epinephrine or a pharmaceutically acceptable salt thereof, as well as a stabilizing agent and a carrier. The stabilizing agent is operable to include citric acid, or a pharmaceutically acceptable salt derived therefrom. Such intranasal compositions as described...